Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2014, Vol. 34 Issue (9): 31-39    DOI: 10.13523/j.cb.20140906
研究报告     
RNA干扰NUP88基因对人乳腺癌MCF-7细胞生长及侵袭力的影响
李玉强, 朱志图, 王巍, 李谌, 徐娜, 王钰, 李男, 孙宏治
辽宁医学院附属第一医院 锦州 121001
Effect of Silencing Nup88 Gene by RNA Interference on Growth and Invasion in Human Breast Cancer MCF-7 Cell
LI Yu-qiang, ZHU Zhi-tu, WANG Wei, LI Chen, XU Na, WANG Yu, LI Nan, SUN Hong-zhi
The First Affiliated Hospital of Liaoning Medcial Uinversity, Jiuzhou 121001, China
 全文: PDF(1432 KB)   HTML
摘要:

目的: 构建重组慢病毒介导的NUP88-shRNA载体,通过RNAi技术分别观察沉默NUP88后对MCF-7增殖,粘附,侵袭和转移情况的影响,为乳腺癌的临床基因治疗寻找新的靶点。方法: 构建NUP88重组慢病毒表达载体,包装后检测滴度,以最佳复感染指数转染乳腺癌MCF-7细胞,利用RT-PCR和Western blot检测各组MCF-7细胞中mRNA和蛋白的表达效率;MTT法和流式细胞仪检测法,检测NUP88基因被干扰后对MCF-7细胞增殖和凋亡的影响;细胞侵袭实验检测NUP88基因被干扰后对MCF-7侵袭力的影响。结果 四组病毒及一组阴性对照均构建成功,滴度均为4E+8TU/ml;RT-PCR和Western blot检测,结果表明:经NUP88-shRNA转染的MCF-7细胞组NUP88 mRNA和蛋白质的表达与经阴性转染组和空白MCF-7细胞组相比,差异明显具有统计学意义(P<0.01);测定NUP88-shRNA1组沉默效率最高,沉默率可达到86%;MTT法结果表明:实验组经NUP88-shRNA1慢病毒转染后细胞增殖程度显著减少,与空白组和对照组相比有显著性差异(P<0.05)。流式细胞仪检测三组MCF-7细胞凋亡结果表明:实验组经慢病毒转染后细胞凋亡率显著增加,与对照组和空白组相比有显著性差异(P<0.05);细胞侵袭实验表明:在肿瘤细胞常规培养24h后,实验组与空白组和阴性对照组比较,穿膜细胞数量明显减少,具有显著性差异(P<0.05) 结论: NUP88重组慢病毒可以通过RNAi成功抑制MCF-7中NUP88基因的表达,并能显著抑制其增殖及远处的侵袭能力。

关键词: 人乳腺癌细胞MCF-7RNAi慢病毒载体NUP88    
Abstract:

Objective: Construct recombinant lentivirus NUP88-shRNA mediated by the carrier, by RNAi technology respectively to observe silence after NUP88 MCF-7 proliferation, adhesion, invasion and metastasis of influence, looking for new targets for clinical gene therapy of breast cancer. Methods Build NUP88 Lentivirus vectors, packaging test after drop, to MOI cell transfection breast cancer MCF-7, using RT-PCR and Western-blot test each mRNA and protein expression in MCF-7 cell efficiency; Determined by MTT method and flow cytometry assay, after testing NUP88 gene is interference effects on MCF-7 cell proliferation and apoptosis; Cell invasion after experimental detection NUP88 gene is interference effects on MCF-7 aggressivity. Results Four groups of virus and a negative control group are building a successful, drop degrees are 4E+ 8 Tu/mL; RT-RCR and Western-blot test, the results show that the NUP88-shRNA transfection of MCF-7 cell group NUP88 mRNA and protein expression and the negative transfection group and blank MCF-7 cell group compared with significant difference statistically significant (P<0.01); Determination of NUP88-shRNA1 group of silence, the most efficient silence rate can reach 86%; Determined by MTT method, the results show that the experimental group after NUP88-shRNA1 Lentivirus transfection cell proliferation significantly reduced, compared with the blank group and the control group with significant difference (P<0.05); Flow cytometry instrument detection of three groups of MCF-7 cell apoptosis results show that the experimental group after lentivirus transfection cell apoptosis rate increased significantly, compared with the control group and blank group had significant difference (P<0.05); Cell invasion experiment show that the tumor cells to conventional training after 24 h, compared with the blank group and the negative control group, experimental group in membrane cells decreased significantly, with significant difference (P<0.05). Conclution NUP88 recombinant lentivirus can suppress the MCF-7 by RNAi successful NUP88 gene expression, and can significantly inhibit the proliferation and invasion ability in the distance.

Key words: NUP88    Human breast cancer cells MCF-7    RNAi    Lentivirus vectors
收稿日期: 2014-07-08 出版日期: 2014-09-25
ZTFLH:  Q78  
基金资助:

辽宁省教育厅教学计划(L201145);辽宁省高等学校优秀人才支持计划(LJQ2011091)资助项目

通讯作者: 孙宏治     E-mail: 18041657171@163.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  

引用本文:

李玉强, 朱志图, 王巍, 李谌, 徐娜, 王钰, 李男, 孙宏治. RNA干扰NUP88基因对人乳腺癌MCF-7细胞生长及侵袭力的影响[J]. 中国生物工程杂志, 2014, 34(9): 31-39.

LI Yu-qiang, ZHU Zhi-tu, WANG Wei, LI Chen, XU Na, WANG Yu, LI Nan, SUN Hong-zhi. Effect of Silencing Nup88 Gene by RNA Interference on Growth and Invasion in Human Breast Cancer MCF-7 Cell. China Biotechnology, 2014, 34(9): 31-39.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20140906        https://manu60.magtech.com.cn/biotech/CN/Y2014/V34/I9/31


[1] 杨清默.CA153,CA125及CEA在乳腺癌诊断中的应用探讨.中国普通外科杂志,2011, 20(11):1265-1267.

[2] Yoo Y D, Han D H, Jang J M, et al. Molecular characteristics of cancer stem-like cells derived from human breast cancer cells. Anticancer Res, 2010, 33(3):763-77.

[3] Ozgün A, Karagoz B, Bilgi O, et al. MicroRNA-21 as an Indicator of aggressive phenotype in breast cancer. Onkologie, 2011, 36(3):115-118.

[4] Seah D S, Scott S M, Openshaw T, et al. Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol, 2012, 45(3):102-108.

[5] Bao P, Li Y, Chen K, et al. The set-u Pof an in vitro model for stable knockdown of MyD88 by lentivirus-based RNAi in IEC-6 cell line and the study on its early apoptosis Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2012, 29(6):1138-1149.

[6] Ramachandran P V, Ignacimuthu S. RNA Interference-A silent but an efficient therapeutic tool. Appl Biochem Biotechnol, 2013, 64(4):361-369.

[7] Zhao Z R, Zhang Z Y, He X Q, et al. Nup88 mRNA overexpression in colorectal cancers and relationshi Pwith p53. Cancer Biomark, 2010-2011, 8(2):73-80.

[8] Hashizume C, Nakano H, Yoshida K, et al. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer, 2010, 24(9):119-123.

[9] Emterling A, Skoglund J, Arbman G, et al. Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology, 2003, 64(4):361-369.

[10] Martínez N, Alonso A, Moragues M D, et al. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res, 1999, 59(21):5408-5411.

[11] 田延锋,赵增仁,李芳,等.NUP88蛋白在乳腺癌中的表达及其临床意义.中国普外科杂志,2011,21(11):1146-1148.

[12] Hashizume C, Nakano H, Yoshida K, et al. Characterization of the role of the tumor marker Nup88 in mitosis. Mol Cancer, 2010, 24(9):119-123.

[13] 王鑫,陈玲,孙飞,等.RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究. 中国生物工程杂,2014, 34 (2):14-20. Wang X, Chen L,Sun F,et al.Experimental study of specific targeted inhibition from RNAi silencing CXCR7 to human colon cancer cell SW620. China Biotechnology, 2014,34(2):14-20.

[14] 陆航,刘学政,孙巨峰,等.RNA干扰沉默CXCR4基因对胃癌细胞SGC7901增殖和侵袭力的影响.中国老年学杂志,2012,13 (3):25-28.

[15] Bao P, Li Y, Chen K, et al. The set-u Pof an in vitro model for stable knockdown of MyD88 by lentivirus-based RNAi in IEC-6 cell line and the study on its early apoptosis. Journal of Biomedical Engineering, 2012, 29(6):1138-1149.

[16] Heaton M P, Kalbfleisch T S, Petrik D T, et al. Genetic Testing for TMEM154 Mutations Associated with Lentivirus Susceptibility in Sheep. International Shee PGenomics Consortium. PLoS One, 2013, 8(2):554-590.

[17] Liu C, Wang L, Li W, et al. Highly efficient generation of transgenic shee Pby lentivirus accompanying the alteration of methylation status. PLoS One, 2011, 8(1):546-614.

[18] 褚波,黄雪峰,唐云明.慢病毒载体及其应用进展.生物医学工程学杂志,2008,1 (2):18-20. Chu B, Huang X F, Tang Y M. Lentiviral vectors and advance in its application. Journal of Biomedical Engineering,2008,25(1):224-226.

[19] Jorgen sen R A, Clust er P D, English J, et al. Chalcone synthase co -suppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single -copy vs. complex T -DNA sequences. Plant Mol Biol, 1996, 31(5):957 -973.

[20] Fire A, Xu S, Montgomery M K, et al. Potent and specific genetic interference by double -stranded RNA in Caenorhabditis elegans. Nature, 1998, 391(66):666-670.

[21] A l derton W K, Cooper C E, Know les R G. Nitric oxide synthases :structure, function and inhibition. Biochem J, 2001,357 (23): 593-615.

[22] Dudzinski D M, Igarashi J, G reif D, et al. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol, 2006, 46: 235-276.

[23] 李玉强,王巍,胡兵兵,等.核孔蛋白复合体蛋白88在乳腺癌细胞株MCF-7和MDA-MB-435S中的表达及意义研究.临床合理用药杂志,2013,4 (6):1-3. Li Y Q,Wang W,Hu B B,et al.Research of NUP88 in breast cancer cell line MCF-7 and MDA-MB-435S the expression and significance. Clinical Rational Drug Use,2013,6(4):1-3.

[24] Agudo D,Gómez-Esquer F, Martínez-Arribas F,et al.Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer, 2004, 10(5):717-715.

[25] Schneider J,Martnez-Arribas F, Torrejon R Nup88 Expression is Associated With Myometrial Invasion in Endometrial Carcinoma J. Int J Gynecol Cancer, 2010, 12(5):804-808.

[1] 赵晓煜,徐祺玲,赵晓东,安云飞. 基因治疗慢病毒载体的转导增强策略*[J]. 中国生物工程杂志, 2021, 41(8): 52-58.
[2] 韩亚丽,杨冠恒,陈雁雯,龚秀丽,张敬之. 表达β-珠蛋白基因的安全性慢病毒载体的优化 *[J]. 中国生物工程杂志, 2018, 38(7): 50-57.
[3] 任琴, 郭志鸿, 王亚军, 谢忠奎, 王若愚. RNA干扰及其在增强作物抵抗有害真核生物研究中的应用[J]. 中国生物工程杂志, 2015, 35(6): 80-89.
[4] 高越, 檀硕, 任兆瑞, 张敬之. 原位染色检测慢病毒载体转录通读方法的建立[J]. 中国生物工程杂志, 2015, 35(5): 55-60.
[5] 薛玉文, 李铁军, 周家名, 陈莉. 多靶向RNA干扰技术在基因治疗中的应用与前景[J]. 中国生物工程杂志, 2015, 35(1): 75-81.
[6] 蒋婷婷, 温晓霞, 陈尧. 沉默c2orf68基因对结直肠癌细胞增殖的影响[J]. 中国生物工程杂志, 2014, 34(2): 7-13.
[7] 王鑫, 陈玲, 孙飞, 陆航. RNAi沉默CXCR7对人结肠癌细胞SW620特异性靶向抑制的实验研究[J]. 中国生物工程杂志, 2014, 34(2): 14-20.
[8] 管洁, 邓瑶, 文波, 陈红, 王文, 谭文杰. 整合缺陷型重组慢病毒载体构建及HCV重组假型慢病毒颗粒的制备与性状分析[J]. 中国生物工程杂志, 2013, 33(6): 62-67.
[9] 李袁飞, 赵和平, 刘静, 朱国强, 张革红, 贾军梅, 杨文慧. 在结肠癌细胞中RNA干扰TGFBR2慢病毒载体的构建及其功能的初步研究[J]. 中国生物工程杂志, 2013, 33(5): 28-34.
[10] 燕海峰, 易康乐, TREFIL P, 胡雄贵, 邓缘, 朱立军. 慢病毒载体导入种蛋内鸡胚技术研究[J]. 中国生物工程杂志, 2012, 32(12): 73-79.
[11] 李建彬, 米志强, 安小平, 谭莉, 陈斌, 王晓娜, 范华昊, 张文慧, 张博, 方祥, 童贻刚. shRNA随机文库结合TK自杀基因筛选靶向HIV-1LTR相关宿主因子[J]. 中国生物工程杂志, 2012, 32(09): 48-54.
[12] 石永乾, 何文腾, 周洋, 焦明霞, 解炳腾, 胡魁, 孔庆然, 刘忠华. 慢病毒载体介导的绿色荧光蛋白转基因标记法研究猪嵌合体制作[J]. 中国生物工程杂志, 2012, 32(08): 68-74.
[13] 赵蕊, 吕静野, 黄海丽, 严启滔. CHD5基因RNAi慢病毒载体的构建及其对结直肠癌细胞生物学功能的影响[J]. 中国生物工程杂志, 2012, 32(05): 7-11.
[14] 钟艳平, 林若芸, 黎丹戎, 胡晓霞, 王琪, 李力. hTERT重组第三代慢病毒载体的构建及其病毒包装鉴定[J]. 中国生物工程杂志, 2011, 31(9): 21-27.
[15] 陈斌, 李建彬, 米志强, 安小平, 李存, 刘大斌, 姜焕焕, 王娟, 黄芬, 张宝中, 范华昊, 何后军, 童贻刚. 利用移码突变和终止密码子提高下游目的基因的表达水平[J]. 中国生物工程杂志, 2011, 31(8): 92-96.